Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area

Read more ››
By: GlobeNewswire - 30 May 2024

Combined General Meeting of June 20, 2024 - Availability of the preparatory documents

Read more ››
By: GlobeNewswire - 30 May 2024

Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024

Read more ››
By: GlobeNewswire - 30 May 2024

Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals

Read more ››
By: GlobeNewswire - 30 May 2024

Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutraceutical Product, GBL-Memory¹

Read more ››
By: GlobeNewswire - 30 May 2024

Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer Indicated in Patients With Prostate Cancer

Read more ››
By: GlobeNewswire - 30 May 2024

Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

Read more ››
By: GlobeNewswire - 30 May 2024

Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board

Read more ››
By: GlobeNewswire - 30 May 2024

Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy

Read more ››
By: GlobeNewswire - 30 May 2024

ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

Read more ››
By: GlobeNewswire - 30 May 2024

Enterome to Participate in the Jefferies Global Healthcare Conference

Read more ››
By: GlobeNewswire - 30 May 2024

Anocca AB and Shinobi Therapeutics Announce Strategic Partnership to Develop Allogeneic TCR-T Cell Therapies in Oncology

Read more ››
By: GlobeNewswire - 30 May 2024

Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

InxMed Reports Positive Phase Ib/II Results for Ifebemtinib in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

BIO 2024 Sets the Stage for Taiwan's Biotech Industry to Shine

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

GlycoNex to Participate in 2024 BIO International Convention

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

Stuttering Market to Register Stunning Growth at a CAGR of 13.4% by 2034 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

Ischemic Heart Disease (IHD) Drugs Market Worth USD 8.46 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.

Read more ››
By: PR Newswire Association LLC. - 30 May 2024

SciBase receives first order in Austria

Read more ››
By: PR Newswire Association LLC. - 30 May 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate